StockData
Johnson & Johnson logo

Johnson & Johnson

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$270.56−2.64 (-0.97%)

Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%

Johnson & Johnson Oral Care (LISTERINE) by Year

Oral Care (LISTERINE) — Worldwide currency (FX) impact YoY (%) (%)

Johnson & Johnson Oral Care (LISTERINE): -3.8% in FY2022, down 5.2 pts from a year earlier. No newer figure appears in the documents we track.

Latest, FY2022
-3.8%
Period ended Jan 1, 2023
Change on a year earlier
-5.2 pts
1.4% in FY2021
History
6 years
Since FY2017
Sources
6
Documents cited below

Where the FY2022 figure comes from

“|| WW | 1,505 | 1,645 | (8.5) | (4.7) | (3.8)”

Source: Form 8-K (a2022q4exhibit991.htm, filed 2023-01-24) ↗

Reported in Form 8-K EX-99.2 Segment Sales Schedule.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedOral Care (LISTERINE) — Worldwide currency (FX) impact YoY (%) (%)Year on yearSource
FY2022Jan 1, 2023-3.8%-5.2 ptsForm 8-K (a2022q4exhibit991.htm, filed 2023-01-24) ↗
FY2021Jan 2, 20221.4%+3.7 ptsForm 8-K (a2021q4exhibit991.htm, filed 2022-01-25) ↗
FY2020Jan 3, 2021-2.3%+0.3 ptsForm 8-K (a2020q4exhibit991.htm, filed 2021-01-26) ↗
FY2019Dec 29, 2019-2.6%-2.5 ptsForm 8-K (a2019q4exhibit991.htm, filed 2020-01-22) ↗
FY2018Dec 30, 2018-0.1%-0.9 ptsForm 8-K (a2018q4exhibit9915.htm, filed 2019-01-22) ↗
FY2017Dec 31, 20170.8%–Form 8-K (a8k2017q4exhibit9915.htm, filed 2018-01-23) ↗

Cite this data

StockData. (2026). Johnson & Johnson Oral Care (LISTERINE) (%), annual FY2017–FY2022 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/ch-oral-care-fx-yoy

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.